THE INFLUENCE OF ISOPROSTANES ON ADP-INDUCED PLATELET AGGREGATION AND CYCLIC AMP-GENERATION IN HUMAN PLATELETS

This publication has 13 references indexed in Scilit:

• Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/ endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor
  Prostaglandins, 1994
• Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia
  Free Radical Biology & Medicine, 1994
• Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-Isoprostane
  Biochemical and Biophysical Research Communications, 1993
• The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist
  Prostaglandins, 1992
• Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
  Journal of Clinical Investigation, 1992
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
  Proceedings of the National Academy of Sciences, 1990
• Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids
  Analytical Biochemistry, 1990
• Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid
  Inflammation Research, 1975
• Effect of Prostaglandin E2 and Aspirin on the Secondary Aggregation of Human Platelets
  Nature New Biology, 1972
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962